|
Volumn 37, Issue 2, 2005, Pages 967-968
|
Kaposi's sarcoma in renal transplant patients: Predisposing factors and prognosis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
AZATHIOPRINE;
CYCLOSPORIN A;
ETOPOSIDE;
HLA DR3 ANTIGEN;
IMMUNOSUPPRESSIVE AGENT;
INTERFERON;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
VINBLASTINE;
ACUTE GRAFT REJECTION;
ADOLESCENT;
ADULT;
AGED;
ANTIGEN DETECTION;
CADAVER KIDNEY;
CANCER CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURGERY;
CAUSE OF DEATH;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
DISEASE PREDISPOSITION;
DRUG WITHDRAWAL;
FEMALE;
FOLLOW UP;
HEMODIALYSIS;
HEPATITIS B;
HEPATITIS C;
HUMAN;
HUMAN TISSUE;
INFECTION RATE;
KAPOSI SARCOMA;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LOW DRUG DOSE;
LYMPH NODE;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PROGNOSIS;
RECIPIENT;
REMISSION;
VISCERA;
|
EID: 17844388364
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.12.034 Document Type: Conference Paper |
Times cited : (19)
|
References (11)
|